arrow-down arrow-left arrow-open-down arrow-open-up arrow-right arrow-up close documents dot-arrow-down dot-arrow-right facebook fb-square google instagram linkedin menu search twitter whatsapp

Médecins Sans Frontières (MSF) is an international, independent, private and non-profit organisation. It comprises 21 institutional members under the MSF International Statutes and 10 specialised organisations, which take charge of specific activities such as humanitarian relief supplies, epidemiological and medical research, and research on humanitarian and social action. As these organisations are controlled by MSF, they are included in the scope of the MSF Financial Report and the figures presented here. These figures describe MSF’s finances on a combined international level. The figures presented here are for the 2016 calendar year. All amounts are presented in millions of euros.

Figures in these tables are rounded, which may result in apparent inconsistencies in totals.

2016 ACTIVITY HIGHLIGHTS

This data groups together direct, remote support and coordination activities. Note: these highlights give an overview of most MSF activities but cannot be considered exhaustive.
9,792,200
outpatient consultations
250,300
births assisted, including caesarean sections
53,300
group mental health sessions
671,700
patients admitted
92,600
major surgical interventions involving the incision, excision, manipulation or suturing of tissue, requiring anaesthesia
20,600
people treated for cholera
Cholera ›
2,536,400
cases of malaria treated
Malaria ›
13,800
patients medically treated for sexual violence
869,100
people vaccinated against measles in response to an outbreak
80,100
severely malnourished children admitted to inpatient feeding programmes
18,200
patients started on tuberculosis first-line treatment
Tuberculosis ›
2,700
patients started on MDR tuberculosis treatment, second-line drugs Tuberculosis ›
169,200
people vaccinated against meningitis in response to an outbreak
Meningitis ›
222,200
patients on first-line antiretroviral treatment at the end of 2016
229,000
individual mental health consultations
10,200
patients on second-line antiretroviral treatment at the end of 2016 (first-line treatment failure)
1,167,600
people vaccinated against yellow fever in response to an outbreak
30,600
migrants and refugees rescued and assisted at sea

MSF PROGRAMMES AROUND THE WORLD


MSF has 468 projects in 71 countries. Click on the map to find out more.

The place names and boundaries used in this report do not reflect any position by MSF on their legal status.

LARGEST COUNTRY PROGRAMMES BASED ON EXPENDITURE

  1. Democratic Republic of Congo
  2. South Sudan
  3. Central African Republic
  4. Yemen
  5. Iraq
  6. Haiti
  7. Syria
  8. Nigeria
  9. Ethiopia
  10. Niger

The total expenditure for our programmes in these 10 countries is 534.8 million euros, 54 per cent of MSF’s operational expenses.

FIND OUT MORE ABOUT MSF FINANCIAL REPORT HERE

CONTEXT OF INTERVENTIONS

Number of projects

MSF STAFF

Staff figures represent total full-time equivalent positions.

INTERNATIONAL STAFF DEPARTURES

Departure figures represent the number of times international staff left on field missions.

WHERE DID THE MONEY GO?

WHERE DID THE MONEY COME FROM?

YEAR-END FINANCIAL POSITION

In millions of euros

The majority of MSF staff (83 per cent) are hired locally in the countries of intervention. Headquarters staff represent 9 per cent of total staff. Departure figures represent the number of times international staff left on field missions. Staff figures represent the total full-time equivalent positions.

Sources of income
As part of MSF’s effort to guarantee its independence and strengthen the organisation’s link with society, we strive to maintain a high level of private income. In 2016, 95 per cent of MSF’s income came from private sources. More than 6.1 million individual donors and private foundations worldwide made this possible. Public institutional agencies providing funding to MSF included, among others, the Humanitarian Aid Office of the European Commission (ECHO) and the governments of Belgium, Germany, Denmark, Canada, Spain, Norway, Japan, Luxembourg, Holland, Ireland, Sweden and Switzerland.

Expenditure is allocated in line with the main activities performed by MSF according to the full cost method. Therefore all expense categories include salaries, direct costs and allocated overheads (e.g. building costs and depreciation).

Programme expenses represent expenses incurred in the field or by headquarters on behalf of the field.

Other expenses comprises costs associated with raising funds from all possible sources, the expenditures incurred in the management and administration of the organisation, as well as income tax paid on commercial activities.

Permanently restricted funds may be capital funds, where donors require the assets to be invested or retained for long-term use rather than expended; or the minimum compulsory level of retained earnings to be maintained in some countries.

Temporarily restricted funds are unspent designated donor funds to a specific purpose (e.g. specific country or project), restricted in time, or required to be invested and retained rather than expended, but without any contractual obligation of reimbursement.

Unrestricted funds are unspent, non-designated donor funds expendable at the discretion of MSF’s trustees in furtherance of our social mission.

Other funds are foundations’ capital and translation adjustments arising from the translation of entities’ financial statements into euros.

MSF’s funds have been built up over the years by surpluses of income over expenses. At the end of 2016, the available portion (excluding permanently restricted funds and capital for foundations) represented 9.2 months of the preceding year’s activity. The purpose of maintaining funds is to meet the following needs: working capital needs over the course of the year, as fundraising traditionally has seasonal peaks while expenditure is relatively constant; swift operational response to humanitarian needs that will be funded by forthcoming public fundraising campaigns and/or by public institutional funding; future major humanitarian emergencies for which sufficient funding cannot be obtained; the sustainability of long-term programmes (e.g. antiretroviral treatment programmes); and a sudden drop in private and/or public institutional funding that cannot be matched in the short term by a reduction in expenditure.

The complete Financial Report is available at www.msf.org